Learn more at LeadIQ.com

Insights

Leadership Promotion Entrada Therapeutics recently promoted Natarajan Sethuraman to President of Research and Development, indicating potential new leadership contacts and decision-makers within the company for sales engagement.

Investment Influx The recent investments from renowned firms like Renaissance Technologies and Acadian Asset Management demonstrate financial growth and stability, opening doors for sales opportunities and partnerships.

Cutting-Edge Technology Entrada Therapeutics' tech stack featuring Oracle, Python, and Akamai signifies a sophisticated technological infrastructure, offering potential avenues for tech-related sales solutions and services.

Strategic Funding With an impressive funding of $100 million secured through direct offerings, Entrada Therapeutics showcases financial robustness, highlighting potential for high-value sales and collaborations.

Clinical Development Focus Entrada's focus on developing innovative medicines for challenging diseases demonstrates a commitment to medical advancements, presenting opportunities for partnership in clinically-driven sales and solutions.

Similar companies to Entrada Therapeutics

Entrada Therapeutics Tech Stack

Entrada Therapeutics uses 8 technology products and services including Akamai, Oracle, web-vitals, and more. Explore Entrada Therapeutics's tech stack below.

Akamai
Content Delivery Network
Oracle
Enterprise
web-vitals
Javascript Libraries
PWA
Miscellaneous
Microsoft
Miscellaneous
Python
Programming Languages
Adobe Tag Manager
Tag Management
Yii
Web Frameworks

Media & News

Entrada Therapeutics's Email Address Formats

Entrada Therapeutics uses at least 1 format(s):

Entrada Therapeutics Email Formats	Example	Percentage
FLast@entradatx.com	JDoe@entradatx.com	88%
First@entradatx.com	John@entradatx.com	7%
Last@entradatx.com	Doe@entradatx.com	4%
First_Last@entradatx.com	John_Doe@entradatx.com	1%

Frequently Asked Questions

Where is Entrada Therapeutics's headquarters located?

Entrada Therapeutics's main headquarters is located at One Design Center Boston, MA 02210 US. The company has employees across 5 continents, including North AmericaAsiaAfrica.

What is Entrada Therapeutics's stock symbol?

Entrada Therapeutics is a publicly traded company; the company's stock symbol is TRDA.

What is Entrada Therapeutics's official website and social media links?

Entrada Therapeutics's official website is entradatx.com and has social profiles on LinkedIn.

How much revenue does Entrada Therapeutics generate?

As of September 2024, Entrada Therapeutics's annual revenue reached $35M.

What is Entrada Therapeutics's SIC code NAICS code?

Entrada Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Entrada Therapeutics have currently?

As of September 2024, Entrada Therapeutics has approximately 195 employees across 5 continents, including North AmericaAsiaAfrica. Key team members include Chief Corporate Affairs Officer: K. M.Vice President | Head Of Cmc: M. M.Head Of Talent Acquisition: G. G.. Explore Entrada Therapeutics's employee directory with LeadIQ.

What industry does Entrada Therapeutics belong to?

Entrada Therapeutics operates in the Biotechnology Research industry.

What technology does Entrada Therapeutics use?

Entrada Therapeutics's tech stack includes AkamaiOracleweb-vitalsPWAMicrosoftPythonAdobe Tag ManagerYii.

What is Entrada Therapeutics's email format?

Entrada Therapeutics's email format typically follows the pattern of . Find more Entrada Therapeutics email formats with LeadIQ.

How much funding has Entrada Therapeutics raised to date?

As of September 2024, Entrada Therapeutics has raised $100M in funding. The last funding round occurred on Jun 24, 2024 for $100M.

When was Entrada Therapeutics founded?

Entrada Therapeutics was founded in 2016.

Entrada Therapeutics

Entrada Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Headquartered in Boston’s Seaport community, Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets long considered inaccessible. Our Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of active moieties into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, we are advancing a robust development portfolio of RNA-, antibody- and enzyme-based programs for the potential treatment of neuromuscular, ocular, metabolic and immunological diseases, among others. Our lead oligonucleotide programs are in development for the treatment of people living with Duchenne muscular dystrophy who are exon 44, 45 and 50 skipping amenable. Entrada has partnered VX-670, a clinical-stage program for the treatment of myotonic dystrophy type 1.

For more information about Entrada, please visit our website, www.entradatx.com

Company Overview

Headquarters: One Design Center Boston, MA 02210 US
Website: entradatx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: TRDA
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 51-200

Media & News

Funding & Financials

$100M
Entrada Therapeutics has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on Jun 24, 2024 in the amount of $100M.
$10M$50M
Entrada Therapeutics's revenue is in the range of $10M$50M

Funding & Financials

$100M
Entrada Therapeutics has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on Jun 24, 2024 in the amount of $100M.
$10M$50M
Entrada Therapeutics's revenue is in the range of $10M$50M

Company Leadership

K. M.
Chief Corporate Affairs Officer
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Vice President | Head Of Cmc
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. G.
Head Of Talent Acquisition
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. P.
Head Of Intellectual Property
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Executive Assistant To The President And Ceo
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

K. R.
Senior Vice President, Head Of People & Culture
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Vice President | Head Of Cmc
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. D.
Vp, Program Governance & Portfolio Management
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. B.
Director, Head Of Total Rewards & Hr Operations
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. S.
Vice President
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Entrada Therapeutics and Millions of Other Companies
Sign up for full access to Entrada Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.